Evercare Dhaka’s hematology dept celebrates 7th BMT Day

Country’s leading healthcare provider Evercare Hospital Dhaka’s Hematology Department recently celebrated its 7th BMT Day at the hospital auditorium.

As part of the celebration, the department organised a day-long scientific seminar which was attended by hematologists from both home and abroad, according to a press statement.

Dr Nasrin Akhter, Dr Menoti Paul Mukti, Dr Mujahida Rahman, Dr Mafruha Akter, Dr Tasneem Ara, Dr Huque Mahfuz, Dr Akhil Ranjon Biswas and Dr Abdullah Az Zubayer Khan attended the seminar as speakers among others.

Besides, Dr Bimalangshu Dey from Boston and Dr Amin Islam from UK joined the session virtually.

Dr Abu Jafar Mohammed Saleh, coordinator and senior consultant of Hematology and Stem Cell Transplant Department of Evercare Hospital Dhaka (EHD) and Evercare Hospital Chattogram (EHC) chaired the scientific session and shared his future plan to make bone marrow transplant available for all patients in Bangladesh.

He said there is no need to go abroad for blood cancer treatment as it is already available in our own country.

Among others, Brig Gen (Rtd) AKM Mustafa Abedin, president of Hematology Society of Bangladesh, Prof Md Salahuddin Shah, chairman of the Department of Hematology BSMMU, Prof Mohiuddin Ahmed Khan, former HOD of DMCH, Prof MA Aziz of BSMMU were present at the event along with other prominent hematologists.

The Evercare Group operates as an integrated healthcare delivery platform in emerging markets across Africa and South Asia, including India, Pakistan, Bangladesh, Kenya and Nigeria. The Group’s portfolio includes 30 hospitals with 3445 beds, 16 clinics, 82 diagnostics centres and two brownfield assets spread over 6 countries. Evercare is proud to be the most diverse healthcare group in the countries it operates in with 11,000 caregivers working together to develop a systemic healthcare change in emerging markets.

Evercare is wholly owned by the Evercare Health Funds, a $1bn emerging markets healthcare fund managed by The Rise Funds, the impact investment platform of global alternative asset manager TPG.